Home » Lupin Gets FDA Final Nod to Market Generic Seasonale Tablets
Lupin Gets FDA Final Nod to Market Generic Seasonale Tablets
Lupin Pharmaceuticals received final approval for its levonorgestrel and ethinyl estradiol tablets, USP 0.15 mg/0.03 mg, from the FDA to market a generic version of Teva Pharmaceuticals’ Seasonale tablets.
RTTNews
RTTNews
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May